These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 31905171)
61. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma. Shevchenko V; Arnotskaya N; Zaitsev S; Sharma A; Sharma HS; Bryukhovetskiy A; Pak O; Khotimchenko Y; Bryukhovetskiy I Int Rev Neurobiol; 2020; 151():185-200. PubMed ID: 32448607 [TBL] [Abstract][Full Text] [Related]
62. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway. Guan Y; He Y; Lv S; Hou X; Li L; Song J J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063 [TBL] [Abstract][Full Text] [Related]
63. Oncogenic miR‑132 sustains proliferation and self‑renewal potential by inhibition of polypyrimidine tract‑binding protein 2 in glioblastoma cells. Lou S; Ji J; Cheng X; Ruan J; Li R; Guo Z Mol Med Rep; 2017 Nov; 16(5):7221-7228. PubMed ID: 28944929 [TBL] [Abstract][Full Text] [Related]
64. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Horvath S; Zhang B; Carlson M; Lu KV; Zhu S; Felciano RM; Laurance MF; Zhao W; Qi S; Chen Z; Lee Y; Scheck AC; Liau LM; Wu H; Geschwind DH; Febbo PG; Kornblum HI; Cloughesy TF; Nelson SF; Mischel PS Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17402-7. PubMed ID: 17090670 [TBL] [Abstract][Full Text] [Related]
65. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling. Han M; Wang S; Fritah S; Wang X; Zhou W; Yang N; Ni S; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J Brain; 2020 Feb; 143(2):512-530. PubMed ID: 31891366 [TBL] [Abstract][Full Text] [Related]
66. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression. Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167 [TBL] [Abstract][Full Text] [Related]
67. Knockdown of carbohydrate sulfotransferase 12 decreases the proliferation and mobility of glioblastoma cells via the WNT/β-catenin pathway. Wang J; Xia X; Tao X; Zhao P; Deng C Bioengineered; 2021 Dec; 12(1):3934-3946. PubMed ID: 34288811 [TBL] [Abstract][Full Text] [Related]
68. Spalt-Like Transcription Factor 1 (SALL1) Gene Expression Inhibits Cell Proliferation and Cell Migration of Human Glioma Cells Through the Wnt/β-Catenin Signaling Pathway. Chi D; Zhang W; Jia Y; Cong D; Hu S Med Sci Monit Basic Res; 2019 May; 25():128-138. PubMed ID: 31040265 [TBL] [Abstract][Full Text] [Related]
69. ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA. Talamillo A; Grande L; Ruiz-Ontañon P; Velasquez C; Mollinedo P; Torices S; Sanchez-Gomez P; Aznar A; Esparis-Ogando A; Lopez-Lopez C; Lafita C; Berciano MT; Montero JA; Vazquez-Barquero A; Segura V; Villagra NT; Pandiella A; Lafarga M; Leon J; Martinez-Climent JA; Sanz-Moreno V; Fernandez-Luna JL Oncogene; 2017 Mar; 36(12):1733-1744. PubMed ID: 27641332 [TBL] [Abstract][Full Text] [Related]
70. Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members. Zhang B; Shen C; Ge F; Ma T; Zhang Z J Neurooncol; 2017 Jul; 133(3):509-518. PubMed ID: 28643150 [TBL] [Abstract][Full Text] [Related]
71. Targeting Wnt/β-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma. Yun EJ; Kim D; Kim S; Hsieh JT; Baek ST Cell Death Dis; 2023 Jul; 14(7):423. PubMed ID: 37443071 [TBL] [Abstract][Full Text] [Related]
72. Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis. Wei B; Wang L; Du C; Hu G; Wang L; Jin Y; Kong D Mol Med Rep; 2015 Apr; 11(4):2548-54. PubMed ID: 25514975 [TBL] [Abstract][Full Text] [Related]
73. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer. Liu X; Liu X; Li J; Ren F Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030 [TBL] [Abstract][Full Text] [Related]
74. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma. Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483 [TBL] [Abstract][Full Text] [Related]
75. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway. Li Q; Ye L; Guo W; Wang M; Huang S; Peng X J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312 [TBL] [Abstract][Full Text] [Related]
76. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis. He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074 [TBL] [Abstract][Full Text] [Related]
77. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway. Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149 [TBL] [Abstract][Full Text] [Related]
78. Wnt/β‑catenin signaling is a novel therapeutic target for tumor suppressor CYLD‑silenced glioblastoma cells. Kanemaru A; Ito Y; Yamaoka M; Shirakawa Y; Yonemaru K; Miyake S; Ando M; Ota M; Masuda T; Mukasa A; Li JD; Saito H; Hide T; Jono H Oncol Rep; 2023 Nov; 50(5):. PubMed ID: 37772388 [TBL] [Abstract][Full Text] [Related]
79. A comprehensive analysis of Wnt/β-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As Li YL; Jin YF; Liu XX; Li HJ Ren Fail; 2018 Nov; 40(1):331-339. PubMed ID: 29633893 [TBL] [Abstract][Full Text] [Related]
80. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer. Wu Y; You Y; Chen L; Liu Y; Liu Y; Lou W; Fu F Gland Surg; 2022 Apr; 11(4):687-701. PubMed ID: 35531115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]